160 related articles for article (PubMed ID: 15711432)
1. Topiramate versus fluvoxamine in the treatment of pathological gambling: a randomized, blind-rater comparison study.
Dannon PN; Lowengrub K; Gonopolski Y; Musin E; Kotler M
Clin Neuropharmacol; 2005; 28(1):6-10. PubMed ID: 15711432
[TBL] [Abstract][Full Text] [Related]
2. Sustained-release bupropion versus naltrexone in the treatment of pathological gambling: a preliminary blind-rater study.
Dannon PN; Lowengrub K; Musin E; Gonopolski Y; Kotler M
J Clin Psychopharmacol; 2005 Dec; 25(6):593-6. PubMed ID: 16282845
[TBL] [Abstract][Full Text] [Related]
3. 12-month follow-up study of drug treatment in pathological gamblers: a primary outcome study.
Dannon PN; Lowengrub K; Musin E; Gonopolsky Y; Kotler M
J Clin Psychopharmacol; 2007 Dec; 27(6):620-4. PubMed ID: 18004130
[TBL] [Abstract][Full Text] [Related]
4. Short-term single-blind fluvoxamine treatment of pathological gambling.
Hollander E; DeCaria CM; Mari E; Wong CM; Mosovich S; Grossman R; Begaz T
Am J Psychiatry; 1998 Dec; 155(12):1781-3. PubMed ID: 9842795
[TBL] [Abstract][Full Text] [Related]
5. Reliability and validity of the pathological gambling adaptation of the Yale-Brown Obsessive-Compulsive Scale (PG-YBOCS).
Pallanti S; DeCaria CM; Grant JE; Urpe M; Hollander E
J Gambl Stud; 2005; 21(4):431-43. PubMed ID: 16311876
[TBL] [Abstract][Full Text] [Related]
6. Nefazodone treatment of pathological gambling: a prospective open-label controlled trial.
Pallanti S; Baldini Rossi N; Sood E; Hollander E
J Clin Psychiatry; 2002 Nov; 63(11):1034-9. PubMed ID: 12444818
[TBL] [Abstract][Full Text] [Related]
7. A randomized double-blind fluvoxamine/placebo crossover trial in pathologic gambling.
Hollander E; DeCaria CM; Finkell JN; Begaz T; Wong CM; Cartwright C
Biol Psychiatry; 2000 May; 47(9):813-7. PubMed ID: 10812040
[TBL] [Abstract][Full Text] [Related]
8. Dual psychiatric diagnosis and substance abuse in pathological gamblers: a preliminary gender comparison study.
Dannon PN; Lowengrub K; Shalgi B; Sasson M; Tuson L; Saphir Y; Kotler M
J Addict Dis; 2006; 25(3):49-54. PubMed ID: 16956869
[TBL] [Abstract][Full Text] [Related]
9. Does sustained-release lithium reduce impulsive gambling and affective instability versus placebo in pathological gamblers with bipolar spectrum disorders?
Hollander E; Pallanti S; Allen A; Sood E; Baldini Rossi N
Am J Psychiatry; 2005 Jan; 162(1):137-45. PubMed ID: 15625212
[TBL] [Abstract][Full Text] [Related]
10. A double-blind, placebo-controlled trial of topiramate for pathological gambling.
Berlin HA; Braun A; Simeon D; Koran LM; Potenza MN; McElroy SL; Fong T; Pallanti S; Hollander E
World J Biol Psychiatry; 2013 Mar; 14(2):121-8. PubMed ID: 21486110
[TBL] [Abstract][Full Text] [Related]
11. Pathological gambling: comorbid psychiatric diagnoses in patients and their families.
Dannon PN; Lowengrub K; Aizer A; Kotler M
Isr J Psychiatry Relat Sci; 2006; 43(2):88-92. PubMed ID: 16910370
[TBL] [Abstract][Full Text] [Related]
12. A pilot placebo-controlled study of fluvoxamine for pathological gambling.
Blanco C; Petkova E; Ibáñez A; Sáiz-Ruiz J
Ann Clin Psychiatry; 2002 Mar; 14(1):9-15. PubMed ID: 12046642
[TBL] [Abstract][Full Text] [Related]
13. Use of Topiramate in Skin-Picking Disorder: A Pilot Study.
Jafferany M; Osuagwu FC
Prim Care Companion CNS Disord; 2017 Jan; 19(1):. PubMed ID: 28129492
[TBL] [Abstract][Full Text] [Related]
14. A double-blind, placebo-controlled study of the opiate antagonist naltrexone in the treatment of pathological gambling urges.
Grant JE; Kim SW; Hartman BK
J Clin Psychiatry; 2008 May; 69(5):783-9. PubMed ID: 18384246
[TBL] [Abstract][Full Text] [Related]
15. Double-blind naltrexone and placebo comparison study in the treatment of pathological gambling.
Kim SW; Grant JE; Adson DE; Shin YC
Biol Psychiatry; 2001 Jun; 49(11):914-21. PubMed ID: 11377409
[TBL] [Abstract][Full Text] [Related]
16. Multicenter investigation of the opioid antagonist nalmefene in the treatment of pathological gambling.
Grant JE; Potenza MN; Hollander E; Cunningham-Williams R; Nurminen T; Smits G; Kallio A
Am J Psychiatry; 2006 Feb; 163(2):303-12. PubMed ID: 16449486
[TBL] [Abstract][Full Text] [Related]
17. An open-label trial of escitalopram in the treatment of pathological gambling.
Black DW; Shaw M; Forbush KT; Allen J
Clin Neuropharmacol; 2007; 30(4):206-12. PubMed ID: 17762317
[TBL] [Abstract][Full Text] [Related]
18. Comorbidity of impulse control disorders in pathological gamblers.
Grant JE; Kim SW
Acta Psychiatr Scand; 2003 Sep; 108(3):203-7. PubMed ID: 12890275
[TBL] [Abstract][Full Text] [Related]
19. Fluvoxamine versus clomipramine in the treatment of obsessive compulsive disorder: a multicenter, randomized, double-blind, parallel group comparison.
Freeman CP; Trimble MR; Deakin JF; Stokes TM; Ashford JJ
J Clin Psychiatry; 1994 Jul; 55(7):301-5. PubMed ID: 8071291
[TBL] [Abstract][Full Text] [Related]
20. Lithium and valproate treatment of pathological gambling: a randomized single-blind study.
Pallanti S; Quercioli L; Sood E; Hollander E
J Clin Psychiatry; 2002 Jul; 63(7):559-64. PubMed ID: 12143910
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
